An analysis of the competitive landscape of the public health insurance exchanges as it has so far unfolded has revealed that despite challenges to date, the exchanges have been attracting new entrants.
An analysis by McKinsey & Company of the competitive landscape of the public health insurance exchanges as it has so far unfolded has revealed that despite challenges to date, the exchanges have been attracting new entrants.
In the 2014 open enrollment period, one-fourth of the carriers offering plans were new entrants—meaning they had no individual insurance experience in states they were entering or no insurance experience at all. Just 4 new entrants did not re-file for 2015. Then in 2015, 28% of carriers were new to their state’s individual insurance market. Preliminary evidence suggests the 2016 open enrollment period will be similar to 2015.
Factors like lowered barriers to entry and the presence of the individual mandate and premium and cost-sharing subsidies likely increasing the number of covered lives have made the exchanges an attractive opportunity for new entrants, according to McKinsey.
However, the analysis points out that it is still too early to tell if the competitiveness of the new entrants will be sustainable.
“Overall, it is clear that the trend toward increased competition on exchanges is continuing,” according to the analysis. “Yet, it is too early to tell how new entrants will fare in the long run, as the market continues to be quite dynamic for all participants.”
Read the full piece: http://bit.ly/1KqSbqI
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen